胎儿监护市场 - 全球产业规模、份额、趋势、机会及预测（按产品、行动装置、性别、方法、应用、最终用户、地区和竞争格局划分，2021-2031 年）

全球胎儿监护市场预计将从 2025 年的 61.6 亿美元成长到 2031 年的 92.5 亿美元，复合年增长率为 7.01%。

此领域着重于持续评估胎儿生命体征，例如心率和子宫收缩，以保障怀孕和分娩期间的健康。早产和高风险怀孕率的上升是推动该领域发展的主要因素，这些情况需要更密切的监测以确保安全。此外，全球孕妇人口老化也增加了对孕妇进行严密监测以应对併发症和降低死亡风险的必要性。例如，美国早产儿基金会（March of Dimes）的一份报告预测，到2024年，美国的早产率将维持在令人担忧的10.4%，这凸显了持续运用这些诊断工具应对孕产妇健康挑战的必要性。

儘管存在这些市场驱动因素，但由于医疗级系统的购买和维护成本高昂，市场发展仍面临重大障碍。这种经济负担限制了小规模诊所和低收入地区采用必要的设备，阻碍了市场的广泛普及。此外，正确分析监测数据所需的专业培训也造成了营运瓶颈。更复杂的是，全球范围内熟练的医护人员短缺，阻碍了这些重要安全通讯协定在标准临床环境中的广泛应用。

市场驱动因素

非侵入性携带式监测技术的突破性进展正推动市场显着成长，使持续胎儿监测不再局限于传统的医院环境。这些无线设备无需将患者束缚在床边设备即可监测生命体征，从而增强了远端系统管理能力，并提高了患者对护理计划的依从性。这些技术进步使得在无需长期住院的情况下，能够及时识别高风险妊娠的併发症，有效平衡了临床安全性和患者自主性。例如，GE医疗的Novii+解决方案于2024年2月获得FDA核准，将无线监测的选择范围扩大到更广泛的患者群体。这项快速创新得益于强大的资金支持；硅谷银行报告称，2024年女性健康领域的创业投资投资将达到26亿美元，为先进诊断工具的开发提供了关键资金。

此外，政府对孕产妇和婴儿健康的支持是推动成长的关键因素，这主要体现在为产科基础设施现代化提供资金方面。公共卫生机构优先考虑降低死亡率和消除医疗保健差距，并推动在农村和医疗服务不足地区推广使用医疗设备。这些措施通常会补贴先进医疗设备的费用，同时强制执行严格的安全标准，以确保公平地获得周产期保健服务。例如，2024年10月，美国卫生资源与服务管理局向旨在改善孕产妇健康和提高服务可近性的州级计划津贴约1,900万美元。此类专项公共资金降低了医疗中心的经济负担，并促进了必要胎儿评估技术的广泛应用。

市场挑战

全球胎儿监护市场发展的主要障碍在于对专业培训的需求以及全球熟练医务人员的短缺。胎儿监护设备会产生复杂的生理数据，例如子宫收缩和胎心率。正确分析这些数据需要高阶临床知识。如果无法准确区分无害的波动和真正的胎儿窘迫，可能会导致严重的健康风险，并为医疗机构带来重大的法律风险。这种对专家解读的依赖造成了瓶颈，能够操作和解读这些诊断工具的人员数量有限，从而限制了其应用。

因此，合格助产士和妇产科医师的短缺直接限制了监测服务的扩展，尤其是在严重短缺的地区。许多医疗机构由于缺乏足够的人员来维持严格的监测通讯协定，被迫限制采用先进的监测系统。根据美国妇产科医师学会预测，到2025年，美国妇产科医师的供应量将仅能满足93.4%的需求。临床需求与劳动力供应之间日益扩大的差距阻碍了这些重要安全措施的普遍应用，从而有效地抑制了市场成长。

市场趋势

将人工智慧 (AI) 应用于预测性胎儿分析正在改变市场格局，使重点从基础数据记录转向即时风险评估。现代演算法能够分析复杂的心率模式，更早检测出异常胎儿讯号，从而为早产和高风险怀孕的临床决策提供支援。监管方面的成就也凸显了这一发展趋势，证实了人工智慧在将监测范围扩展到怀孕更脆弱阶段的效用。例如，PeriGen 的 Patterns 3.0 软体于 2025 年 2 月获得 FDA核准，将人工智慧驱动的模式识别扩展到妊娠 32 週的胎儿。这些创新使医疗团队能够更准确地处理严重病例，并减少对主观分析的依赖，而主观分析常常会导致急诊护理的延误。

同时，智慧型手机连接的智慧监测工具的兴起推动了产前护理服务的去中心化，使孕妇能够在家中进行临床级别的检测。这些携带式装置可直接与行动应用程式连接，并将影像和资料传输给医疗服务提供者进行远端评估，从而显着减少了就医次数。 2025年11月，Parsenmore公司获得FDA的全新上市许可，进一步强化了这种以消费者为主导的连线健诊医疗模式。该公司基于家庭的产前超音波平台使用智慧型手机底座，使患者能够自行进行扫描。这项功能弥合了患者与产科医生之间的地域差距，并提供持续的诊断级资讯流，有效解决了服务不足地区的医疗问题。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球胎儿监护市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（超音波设备、设备、胎儿分娩监视器、子宫收缩监测仪、胎儿电极、胎儿多普勒设备、遥测设备、配件及耗材、其他）
  • 便携性（可携式系统和非可携式系统）
  • 按方法（侵入性/非侵入性）
  • 使用方式（交付前、交付期间）
  • 依最终使用者（医院、妇产科诊所、居家医疗环境）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美胎儿监护市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲胎儿监护市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区胎儿监护市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲胎儿监护市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲胎儿监护市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球胎儿照护市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Medtronic Plc
• Cardinal Health Inc.
• Koninklijke Philips NV
• Siemens Healthineers AG
• GE Healthcare Technologies Inc.
• FUJIFILM SonoSite, Inc
• Natus Medical Incorporated
• Huntleigh Healthcare Limited
• CooperCompanies Inc.
• CONTEC Medical Systems Co., Ltd

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Fetal Monitoring Market is projected to expand from USD 6.16 Billion in 2025 to USD 9.25 Billion by 2031, reflecting a compound annual growth rate of 7.01%. This sector focuses on the continuous evaluation of fetal vital signs, such as heart rates and uterine contractions, to safeguard health during pregnancy and labor. Growth is largely fueled by the rising incidence of preterm births and high-risk pregnancies, which demand intense surveillance to ensure safety. Furthermore, increasing maternal age globally has heightened the necessity for careful monitoring to handle complications and reduce mortality risks. For example, the March of Dimes reported that the preterm birth rate in the United States held steady at a worrying 10.4% in 2024, underscoring the ongoing need for these diagnostic tools to tackle maternal health challenges.

Despite these drivers, market progress faces significant hurdles due to the high costs involved in purchasing and maintaining medical-grade systems. This financial burden restricts the deployment of essential equipment in smaller clinics and lower-income areas, thereby limiting broader market penetration. Moreover, the need for specialized training to correctly analyze monitoring data creates operational bottlenecks. A global scarcity of skilled healthcare practitioners further complicates matters, preventing the widespread application of these critical safety protocols in standard medical practice.

Market Driver

The market is being significantly propelled by breakthroughs in non-invasive and portable monitoring technologies, which allow for continuous fetal observation beyond the confines of traditional hospitals. These wireless devices monitor vital signs without keeping patients tethered to bedside machines, enhancing remote management capabilities and improving adherence to care plans. Such technological evolution permits the timely identification of complications in high-risk pregnancies without necessitating extended hospital stays, effectively balancing clinical safety with patient freedom. Illustrating this trend, GE HealthCare received FDA clearance in February 2024 for its Novii+ solution, expanding wireless monitoring options for a wider demographic. This rapid innovation is supported by strong financial backing; Silicon Valley Bank reported that venture capital investment in women's health hit $2.6 billion in 2024, providing crucial capital for developing these advanced diagnostic tools.

Furthermore, government support for maternal and infant health serves as a vital engine for growth by directing funds toward modernizing obstetric infrastructure. Public health bodies are prioritizing spending to lower mortality rates and close healthcare gaps, facilitating the purchase of medical-grade equipment in rural and underserved communities. These initiatives often subsidize the expense of sophisticated devices while enforcing strict safety standards to guarantee fair access to perinatal services. For instance, in October 2024, the Health Resources and Services Administration granted approximately $19 million to state-level projects designed to improve maternal health results and service availability. Such targeted public funding reduces economic obstacles for medical centers, encouraging the widespread adoption of necessary fetal assessment technologies.

Market Challenge

A major obstacle hindering the Global Fetal Monitoring Market is the necessity for specialized training alongside a worldwide lack of skilled healthcare workers. Fetal monitoring devices produce intricate physiological data, such as uterine contractions and fetal heart rate rhythms, which require high-level clinical knowledge for proper analysis. Failing to accurately differentiate between harmless variations and actual fetal distress can result in serious health consequences and substantial legal risks for healthcare providers. This reliance on expert interpretation generates a bottleneck, as the rollout of these diagnostic tools is limited by the availability of personnel capable of operating them and interpreting the results.

Consequently, the shortage of qualified midwives and obstetricians directly limits the ability to scale monitoring services, especially in areas with severe workforce shortages. Many medical institutions are compelled to restrict the implementation of advanced monitoring systems because they lack adequate staff to uphold rigorous surveillance protocols. According to the American College of Obstetricians and Gynecologists, the supply of obstetrician-gynecologists in the United States satisfied only 93.4% of the demand in 2025. This expanding disparity between clinical needs and workforce availability impedes the universal application of these vital safety measures, effectively stalling the market's growth.

Market Trends

The incorporation of Artificial Intelligence (AI) into predictive fetal analytics is transforming the market, shifting focus from basic data recording to real-time risk assessment. Modern algorithms are capable of examining complex heart rate patterns to detect distress signals sooner, thereby aiding clinical decisions regarding preterm and high-risk pregnancies. This evolution is highlighted by regulatory achievements that confirm AI's utility in broadening surveillance to include more vulnerable stages of gestation. For example, PeriGen obtained FDA clearance in February 2025 for its Patterns 3.0 software, extending its AI-driven pattern recognition to fetuses as young as 32 weeks. These innovations enable medical teams to handle critical cases with higher accuracy, diminishing the dependence on subjective analysis that frequently causes delays in acute care environments.

In parallel, the rise of smartphone-integrated smart monitoring tools is decentralizing prenatal services, empowering expectant mothers to conduct clinical-quality checks from home. These portable devices connect directly with mobile apps to send images and data to healthcare providers for remote evaluation, significantly lowering the frequency of required clinic visits. This shift toward consumer-oriented, connected healthcare was reinforced when Pulsenmore received FDA De Novo marketing authorization in November 2025 for its home-based prenatal ultrasound platform, which uses a smartphone dock to facilitate patient-guided scanning. This functionality effectively tackles the issue of care deserts by bridging the geographical gap between patients and obstetricians while ensuring a consistent flow of diagnostic-grade information.

Key Market Players

• Medtronic Plc
• Cardinal Health Inc.
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• GE Healthcare Technologies Inc.
• FUJIFILM SonoSite, Inc
• Natus Medical Incorporated
• Huntleigh Healthcare Limited
• CooperCompanies Inc.
• CONTEC Medical Systems Co., Ltd

Report Scope

In this report, the Global Fetal Monitoring Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fetal Monitoring Market, By Product

• Ultrasound
• Device
• Fetal Monitors
• Uterine Contraction Monitors
• Fetal Electrodes
• Fetal Doppler Device
• Telemetry Device
• Accessories and Consumables
• Others

Fetal Monitoring Market, By Portability

• Portable System and Non-Portable System

Fetal Monitoring Market, By Method

• Invasive and Non-invasive

Fetal Monitoring Market, By Application

• Antepartum
• Intrapartum

Fetal Monitoring Market, By End User

• Hospitals
• Obstetrics & Gynecology clinic
• Home Care Setting

Fetal Monitoring Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fetal Monitoring Market.

Available Customizations:

Global Fetal Monitoring Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fetal Monitoring Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Ultrasound, Device, Fetal Monitors, Uterine Contraction Monitors, Fetal Electrodes, Fetal Doppler Device, Telemetry Device, Accessories and Consumables, Others)
  • 5.2.2. By Portability (Portable System and Non-Portable System)
  • 5.2.3. By Method (Invasive and Non-invasive)
  • 5.2.4. By Application (Antepartum, Intrapartum)
  • 5.2.5. By End User (Hospitals, Obstetrics & Gynecology clinic, Home Care Setting)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Fetal Monitoring Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Portability
  • 6.2.3. By Method
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Fetal Monitoring Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Portability
      • 6.3.1.2.3. By Method
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Fetal Monitoring Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Portability
      • 6.3.2.2.3. By Method
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Fetal Monitoring Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Portability
      • 6.3.3.2.3. By Method
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Fetal Monitoring Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Portability
  • 7.2.3. By Method
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Fetal Monitoring Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Portability
      • 7.3.1.2.3. By Method
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. France Fetal Monitoring Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Portability
      • 7.3.2.2.3. By Method
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Fetal Monitoring Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Portability
      • 7.3.3.2.3. By Method
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Fetal Monitoring Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Portability
      • 7.3.4.2.3. By Method
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Fetal Monitoring Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Portability
      • 7.3.5.2.3. By Method
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia Pacific Fetal Monitoring Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Portability
  • 8.2.3. By Method
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Fetal Monitoring Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Portability
      • 8.3.1.2.3. By Method
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Fetal Monitoring Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Portability
      • 8.3.2.2.3. By Method
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Fetal Monitoring Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Portability
      • 8.3.3.2.3. By Method
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Fetal Monitoring Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Portability
      • 8.3.4.2.3. By Method
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Fetal Monitoring Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Portability
      • 8.3.5.2.3. By Method
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. Middle East & Africa Fetal Monitoring Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Portability
  • 9.2.3. By Method
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Fetal Monitoring Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Portability
      • 9.3.1.2.3. By Method
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Fetal Monitoring Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Portability
      • 9.3.2.2.3. By Method
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Fetal Monitoring Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Portability
      • 9.3.3.2.3. By Method
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. South America Fetal Monitoring Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Portability
  • 10.2.3. By Method
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Fetal Monitoring Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Portability
      • 10.3.1.2.3. By Method
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Fetal Monitoring Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Portability
      • 10.3.2.2.3. By Method
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Fetal Monitoring Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Portability
      • 10.3.3.2.3. By Method
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Fetal Monitoring Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic Plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cardinal Health Inc.
• 15.3. Koninklijke Philips N.V.
• 15.4. Siemens Healthineers AG
• 15.5. GE Healthcare Technologies Inc.
• 15.6. FUJIFILM SonoSite, Inc
• 15.7. Natus Medical Incorporated
• 15.8. Huntleigh Healthcare Limited
• 15.9. CooperCompanies Inc.
• 15.10. CONTEC Medical Systems Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer